1. Wang, Jing, Zhou, Yan, Zhang, Donghui, Wang, Hui, Zhao, Liang. 2022. CRIP1 suppresses BBOX1-mediated carnitine metabolism to promote stemness in hepatocellular carcinoma. In The EMBO journal, 41, e110218. doi:10.15252/embj.2021110218. https://pubmed.ncbi.nlm.nih.gov/35775648/
2. Tang, Peixia, Yu, Zhen, Sun, Hao, Qiu, Lugui, Hao, Mu. 2024. CRIP1 involves the pathogenesis of multiple myeloma via dual-regulation of proteasome and autophagy. In EBioMedicine, 100, 104961. doi:10.1016/j.ebiom.2023.104961. https://pubmed.ncbi.nlm.nih.gov/38199044/
3. Ma, Bei-Bei, Zhang, Ting-Juan, Wang, Cui-Zhu, Lin, Jiang, Qian, Jun. 2020. Methylation-independent CRIP1 expression is a potential biomarker affecting prognosis in cytogenetically normal acute myeloid leukemia. In American journal of translational research, 12, 4840-4852. doi:. https://pubmed.ncbi.nlm.nih.gov/33042393/
4. Ye, Chengyu, Ma, Shenglin, Xia, Bing, Zheng, Cuiping. 2019. Weighted Gene Coexpression Network Analysis Identifies Cysteine-Rich Intestinal Protein 1 (CRIP1) as a Prognostic Gene Associated with Relapse in Patients with Acute Myeloid Leukemia. In Medical science monitor : international medical journal of experimental and clinical research, 25, 7396-7406. doi:10.12659/MSM.918092. https://pubmed.ncbi.nlm.nih.gov/31577790/
5. Gao, Yan, Li, Jin-Yuan, Mao, Jia-Ying, Jiang, Lu, Li, Xue-Ping. 2022. Comprehensive Analysis of CRIP1 Expression in Acute Myeloid Leukemia. In Frontiers in genetics, 13, 923568. doi:10.3389/fgene.2022.923568. https://pubmed.ncbi.nlm.nih.gov/35938037/